Selected research
Industry Research
Therapeutic Radioisotopes Industry Research Report 2026
Market perspective
The global Therapeutic Radioisotopes market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Therapeutic Radioisotopes is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Therapeutic Radioisotopes is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Therapeutic Radioisotopes is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Therapeutic Radioisotopes include Novartis, Bayer, Q BioMed, Mundipharma, Lantheus, Jubilant Radiopharma, International Isotopes, Dongcheng and Curium Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Therapeutic Radioisotopes market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Therapeutic Radioisotopes Market by Company
Novartis
Bayer
Q BioMed
Mundipharma
Lantheus
Jubilant Radiopharma
International Isotopes
Dongcheng
Curium Pharmaceuticals
China Isotope & Radiation
Aurobindo Pharma
Therapeutic Radioisotopes Segment by Type
Lutetium-177
Radium-223
Iodine-131
Other
Therapeutic Radioisotopes Segment by Application
Lymphoma
Thyroid
Bone Metastasis
Other
Therapeutic Radioisotopes Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Therapeutic Radioisotopes market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Therapeutic Radioisotopes and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Therapeutic Radioisotopes.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Therapeutic Radioisotopes manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Therapeutic Radioisotopes by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Therapeutic Radioisotopes in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Lutetium-177
- Radium-223
- Iodine-131
- Other
Applications
- Lymphoma
- Thyroid
- Bone Metastasis
- Other
Companies covered
- Novartis
- Bayer
- Q BioMed
- Mundipharma
- Lantheus
- Jubilant Radiopharma
- International Isotopes
- Dongcheng
- Curium Pharmaceuticals
- China Isotope & Radiation
- Aurobindo Pharma
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Therapeutic Radioisotopes Market Size (2021-2032)
- 2.2.2 Global Therapeutic Radioisotopes Sales (2021-2032)
- 2.2.3 Global Therapeutic Radioisotopes Market Average Price (2021-2032)
- 2.3 Therapeutic Radioisotopes by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Lutetium-177
- 2.3.3 Radium-223
- 2.3.4 Iodine-131
- 2.3.5 Other
- 2.4 Therapeutic Radioisotopes by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Lymphoma
- 2.4.3 Thyroid
- 2.4.4 Bone Metastasis
- 2.4.5 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Therapeutic Radioisotopes Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Therapeutic Radioisotopes Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Therapeutic Radioisotopes Revenue of Manufacturers (2021-2026)
- 3.4 Global Therapeutic Radioisotopes Average Price by Manufacturers (2021-2026)
- 3.5 Global Therapeutic Radioisotopes Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Therapeutic Radioisotopes, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Therapeutic Radioisotopes, Product Type & Application
- 3.8 Global Manufacturers of Therapeutic Radioisotopes, Established Date
- 3.9 Global Therapeutic Radioisotopes Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Novartis
- 4.1.1 Novartis Company Information
- 4.1.2 Novartis Business Overview
- 4.1.3 Novartis Therapeutic Radioisotopes Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Novartis Therapeutic Radioisotopes Product Portfolio
- 4.1.5 Novartis Recent Developments
- 4.2 Bayer
- 4.2.1 Bayer Company Information
- 4.2.2 Bayer Business Overview
- 4.2.3 Bayer Therapeutic Radioisotopes Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Bayer Therapeutic Radioisotopes Product Portfolio
- 4.2.5 Bayer Recent Developments
- 4.3 Q BioMed
- 4.3.1 Q BioMed Company Information
- 4.3.2 Q BioMed Business Overview
- 4.3.3 Q BioMed Therapeutic Radioisotopes Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Q BioMed Therapeutic Radioisotopes Product Portfolio
- 4.3.5 Q BioMed Recent Developments
- 4.4 Mundipharma
- 4.4.1 Mundipharma Company Information
- 4.4.2 Mundipharma Business Overview
- 4.4.3 Mundipharma Therapeutic Radioisotopes Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Mundipharma Therapeutic Radioisotopes Product Portfolio
- 4.4.5 Mundipharma Recent Developments
- 4.5 Lantheus
- 4.5.1 Lantheus Company Information
- 4.5.2 Lantheus Business Overview
- 4.5.3 Lantheus Therapeutic Radioisotopes Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Lantheus Therapeutic Radioisotopes Product Portfolio
- 4.5.5 Lantheus Recent Developments
- 4.6 Jubilant Radiopharma
- 4.6.1 Jubilant Radiopharma Company Information
- 4.6.2 Jubilant Radiopharma Business Overview
- 4.6.3 Jubilant Radiopharma Therapeutic Radioisotopes Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Jubilant Radiopharma Therapeutic Radioisotopes Product Portfolio
- 4.6.5 Jubilant Radiopharma Recent Developments
- 4.7 International Isotopes
- 4.7.1 International Isotopes Company Information
- 4.7.2 International Isotopes Business Overview
- 4.7.3 International Isotopes Therapeutic Radioisotopes Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 International Isotopes Therapeutic Radioisotopes Product Portfolio
- 4.7.5 International Isotopes Recent Developments
- 4.8 Dongcheng
- 4.8.1 Dongcheng Company Information
- 4.8.2 Dongcheng Business Overview
- 4.8.3 Dongcheng Therapeutic Radioisotopes Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Dongcheng Therapeutic Radioisotopes Product Portfolio
- 4.8.5 Dongcheng Recent Developments
- 4.9 Curium Pharmaceuticals
- 4.9.1 Curium Pharmaceuticals Company Information
- 4.9.2 Curium Pharmaceuticals Business Overview
- 4.9.3 Curium Pharmaceuticals Therapeutic Radioisotopes Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Curium Pharmaceuticals Therapeutic Radioisotopes Product Portfolio
- 4.9.5 Curium Pharmaceuticals Recent Developments
- 4.10 China Isotope & Radiation
- 4.10.1 China Isotope & Radiation Company Information
- 4.10.2 China Isotope & Radiation Business Overview
- 4.10.3 China Isotope & Radiation Therapeutic Radioisotopes Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 China Isotope & Radiation Therapeutic Radioisotopes Product Portfolio
- 4.10.5 China Isotope & Radiation Recent Developments
- 4.11 Aurobindo Pharma
- 4.11.1 Aurobindo Pharma Company Information
- 4.11.2 Aurobindo Pharma Business Overview
- 4.11.3 Aurobindo Pharma Therapeutic Radioisotopes Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Aurobindo Pharma Therapeutic Radioisotopes Product Portfolio
- 4.11.5 Aurobindo Pharma Recent Developments
5 Global Therapeutic Radioisotopes Market Scenario by Region
- 5.1 Global Therapeutic Radioisotopes Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Therapeutic Radioisotopes Sales by Region: 2021-2032
- 5.2.1 Global Therapeutic Radioisotopes Sales by Region: 2021-2026
- 5.2.2 Global Therapeutic Radioisotopes Sales by Region: 2027-2032
- 5.3 Global Therapeutic Radioisotopes Revenue by Region: 2021-2032
- 5.3.1 Global Therapeutic Radioisotopes Revenue by Region: 2021-2026
- 5.3.2 Global Therapeutic Radioisotopes Revenue by Region: 2027-2032
- 5.4 North America Therapeutic Radioisotopes Market Facts & Figures by Country
- 5.4.1 North America Therapeutic Radioisotopes Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Therapeutic Radioisotopes Sales by Country (2021-2032)
- 5.4.3 North America Therapeutic Radioisotopes Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Therapeutic Radioisotopes Market Facts & Figures by Country
- 5.5.1 Europe Therapeutic Radioisotopes Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Therapeutic Radioisotopes Sales by Country (2021-2032)
- 5.5.3 Europe Therapeutic Radioisotopes Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Therapeutic Radioisotopes Market Facts & Figures by Country
- 5.6.1 Asia Pacific Therapeutic Radioisotopes Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Therapeutic Radioisotopes Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Therapeutic Radioisotopes Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Therapeutic Radioisotopes Market Facts & Figures by Country
- 5.7.1 South America Therapeutic Radioisotopes Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Therapeutic Radioisotopes Sales by Country (2021-2032)
- 5.7.3 South America Therapeutic Radioisotopes Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Therapeutic Radioisotopes Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Therapeutic Radioisotopes Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Therapeutic Radioisotopes Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Therapeutic Radioisotopes Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Therapeutic Radioisotopes Sales by Type (2021-2032)
- 6.1.1 Global Therapeutic Radioisotopes Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Therapeutic Radioisotopes Sales Market Share by Type (2021-2032)
- 6.2 Global Therapeutic Radioisotopes Revenue by Type (2021-2032)
- 6.2.1 Global Therapeutic Radioisotopes Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Therapeutic Radioisotopes Revenue Market Share by Type (2021-2032)
- 6.3 Global Therapeutic Radioisotopes Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Therapeutic Radioisotopes Sales by Application (2021-2032)
- 7.1.1 Global Therapeutic Radioisotopes Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Therapeutic Radioisotopes Sales Market Share by Application (2021-2032)
- 7.2 Global Therapeutic Radioisotopes Revenue by Application (2021-2032)
- 7.2.1 Global Therapeutic Radioisotopes Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Therapeutic Radioisotopes Revenue Market Share by Application (2021-2032)
- 7.3 Global Therapeutic Radioisotopes Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Therapeutic Radioisotopes Value Chain Analysis
- 8.1.1 Therapeutic Radioisotopes Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Therapeutic Radioisotopes Production Mode & Process
- 8.2 Therapeutic Radioisotopes Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Therapeutic Radioisotopes Distributors
- 8.2.3 Therapeutic Radioisotopes Customers
9 Global Therapeutic Radioisotopes Analyzing Market Dynamics
- 9.1 Therapeutic Radioisotopes Industry Trends
- 9.2 Therapeutic Radioisotopes Industry Drivers
- 9.3 Therapeutic Radioisotopes Industry Opportunities and Challenges
- 9.4 Therapeutic Radioisotopes Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst